Epirium
San Diego, US · 3 known investors
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy. The company's lead compound, EPM-01, is in Phase 1 clinical development for Becker muscular dystrophy.
BiotechMedical Devices
Founders & leadership
PT
Pam TaubM.D., FACC, Founder
AM
Alan MaiselM.D., Founder
FV
Francisco VillarrealM.D., Ph.D., Founder
JT
Jonathan TaubFounder, Chief Executive Officer
GC
Guillermo CeballosM.D., Founding Scientist
RJ
Russell J. CoxPresident and CEO